Published Online: Thursday, February 1, 2007

The first major casualty of the retail industry's ongoing generic drug price wars appears to be BJ's Wholesale Club, a 171-unit warehouse store chain that has announced plans to close down its in-store pharmacies due to shrinking profit margins. BJ's opened its first pharmacy less than 5 years ago. It followed the lead of Wal-Mart, Target, and other major chains by slashing prices on prescriptions for hundreds of generic drugs to $4 last fall. Although industry analysts cited a variety of factors in the chain's decision to abandon its pharmacy operations, depressed profits due to the generic prescription price competition may have been the final straw for BJ's.

The closure of all 46 in-store pharmacies was estimated to have been complete by February 3, 2007. A spokesperson for BJ's said the company would not comment on the decision to disband the pharmacy. In a conference call with investors last week, however, Interim Chief Executive Officer Herb Zarkin said BJ's prescription business was not growing. "It just didn't make a lot of sense for us to keep putting the investment in," he said.

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues